Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,994 public trials 1,209 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Active, Not Recruiting

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

NCT04478279

Conditions: Astrocytoma, Brain Cancer, Brain Diseases, +43 more
Locations: University of California, San Francisco San Francisco, California, United States

Sarah Cannon Research Institute Denver, Colorado, United States

Northwestern Medicine Cancer Centers Warrenville, Illinois, United States

START Midwest Grand Rapids, Michigan, United States

View Trial Details

Active, Not Recruiting

Eye Plaque Brachytherapy for Ocular Melanoma

NCT06432660

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +12 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Active, Not Recruiting

Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)

NCT03405792

Conditions: Astrocytoma, Glioblastoma, Glioblastoma, WHO Grade IV, +8 more
Locations: University of Florida Health Gainesville, Florida, United States

View Trial Details

Active, Not Recruiting

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

NCT05358938

Conditions: Adenocarcinoma, Behavior, Carcinoma, +24 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Active, Not Recruiting

Pilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain Tumors

NCT01535911

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +14 more
Locations: Michigan State University/Sparrow Hospital East Lansing, Michigan, United States

View Trial Details

Active, Not Recruiting

A Phase 2 Clinical Trial of Neoadjuvant Relatlimab and Nivolumab in High Risk, Clinical Stage II Cutaneous Melanoma

NCT05418972

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Melanoma Institute Australia Wollstonecraft, New South Wales, Australia

View Trial Details

Active, Not Recruiting

Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma

NCT03543969

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +13 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Active, Not Recruiting

Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

NCT04459273

Conditions: Adenocarcinoma, Adrenal Gland Diseases, Adrenal Gland Neoplasms, +77 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Active, Not Recruiting

Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma

NCT03389230

Conditions: Astrocytoma, Glioblastoma, Glioma, +11 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration

NCT04201457

Conditions: Glioma, High Grade Glioma (HGG) of the Brain With BRAF Aberration, Low Grade Glioma (LGG) of Brain With BRAF Aberration, +8 more
Locations: Phoenix Children's Hospital Phoenix, Arizona, United States

Children's Hospital Los Angeles Los Angeles, California, United States

Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States

Children's Hospital Colorado Aurora, Colorado, United States

View all 15 locations

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions